Spatial and temporal localization of the melanocortin 1 receptor and its ligand α-Melanocyte-stimulating hormone during cutaneous wound repair

Journal of Histochemistry and Cytochemistry

Volumn 59, Issue 3, 2011, Pages 278-288

  Muffley, Lara A ^a   Zhu, Kathy Q ^a   Engrav, Loren H ^a   Gibran, Nicole S ^a   Hocking, Anne M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

melanocyte stimulating hormone; Cutaneous wound repair; Hypertrophic scar; Immunohisto chemistry; Melanocortin 1 receptor

Indexed keywords

ALPHA INTERMEDIN; MELANOCORTIN 1 RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BURN; CHILD; CONTROLLED STUDY; DERMIS; EPIDERMIS; EPITHELIZATION; FEMALE; FIBROBLAST; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; INFLAMMATION; INFLAMMATORY CELL; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SCHOOL CHILD; SEBACEOUS GLAND; SKIN; SKIN INJURY; STROMA CELL; WOUND HEALING;

ADULT; ALPHA-MSH; ANIMALS; BURNS; CHILD; CICATRIX, HYPERTROPHIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; RECEPTOR, MELANOCORTIN, TYPE 1; WOUND HEALING; WOUNDS AND INJURIES;

MURINAE;

EID: 80051741396     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155410397999     Document Type: Article

References (34)

1. Beaumont KA, Newton RA, Smit DJ, Leonard JH, Stow JL, Sturm RA. 2005. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet. 14:2145-2154.
2. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, Luger TA. 1996. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol. 156:2517-2521.
3. Bohm M, Luger TA, Tobin DJ, Garcia-Borron JC. 2006. Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol. 126:1966-1975.
4. Bohm M, Metze D, Schulte U, Becher E, Luger TA, Brzoska T. 1999. Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp Dermatol. 8:453-461.
5. Bohm M, Raghunath M, Sunderkotter C, Schiller M, Stander S, Brzoska T, Cauvet T, Schioth HB, Schwarz T, Luger TA. 2004. Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. J Biol Chem. 279:6959-6966.
6. Bonfiglio V, Camillieri G, Avitabile T, Leggio GM, Drago F. 2006. Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Exp Eye Res. 83:1366-1372.
7. Botchkarev VA, Botchkareva NV, Slominski A, Roloff B, Luger T, Paus R. 1999. Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann N Y Acad Sci. 885:433-439.
8. Brzoska T, Luger TA, Maaser C, Abels C, Bohm M. 2008. Alpha-Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immunemediated inflammatory diseases. Endocr Rev. 29:581-602.
9. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM. 1996. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides. 17:675-679.
10. Chakraborty AK, Funasaka Y, Pawelek JM, Nagahama M, Ito A, Ichihashi M. 1999. Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Invest Dermatol. 112:853-860.
11. Desmouliere A, Chaponnier C, Gabbiani G. 2005. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 13:7-12.
12. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G. 1994. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol. 145:105-113.
13. Gurtner GC, Werner S, Barrandon Y, Longaker MT. 2008. Wound repair and regeneration. Nature. 453:314-321.
14. Harunari N, Zhu KQ, Armendariz RT, Deubner H, Muangman P, Carrougher GJ, Isik FF, Gibran NS, Engrav LH. 2006. Histology of the thick scar on the female, red Duroc pig: final similarities to human hypertrophic scar. Burns. 32:669-677.
15. Hill RP, MacNeil S, Haycock JW. 2006. Melanocyte stimulating hormone peptides inhibit TNF-alpha signaling in human dermal fibroblast cells. Peptides. 27:421-430.
16. Kokot A, Sindrilaru A, Schiller M, Sunderkotter C, Kerkhoff C, Eckes B, Scharffetter-Kochanek K, Luger TA, Bohm M. 2009. Alphamelanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma? Arthritis Rheum. 60:592-603.
17. Lin JY, Fisher DE. 2007. Melanocyte biology and skin pigmentation. Nature. 445:843-850.
18. Mandrika I, Muceniece R, Wikberg JE. 2001. Effects of melanocortin peptides on lipopolysaccharide/interferon-gammainduced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem Pharmacol. 61:613-621.
19. Martin P. 1997. Wound healing-aiming for perfect skin regeneration. Science. 276:75-81.
20. Mazurkiewicz JE, Corliss D, Slominski A. 2000. Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. J Histochem Cytochem. 48:905-914.
21. Muangman P, Muffley LA, Anthony JP, Spenny ML, Underwood RA, Olerud JE, Gibran NS. 2004. Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen. 12:44-52.
22. Olerud JE, Chiu DS, Usui ML, Gibran NS, Ansel JC. 1998. Protein gene product 9.5 is expressed by fibroblasts in human cutaneous wounds. J Invest Dermatol. 111:565-572.
23. Redondo P, Garcia-Foncillas J, Okroujnov I, Bandres E. 1998. Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res. 290:425-428.
24. Rees JL. 2003. Genetics of hair and skin color. Annu Rev Genet. 37:67-90.
25. Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schioth HB. 2004. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol. 123:917-923.
26. Sanchez-Laorden BL, Sanchez-Mas J, Turpin MC, Garcia-Borron JC, Jimenez-Cervantes C. 2006. Variant amino acids in different domains of the human melanocortin 1 receptor impair cell surface expression. Cell Mol Biol (Noisy-le-grand). 52:39-46.
27. Scott JR, Muangman PR, Tamura RN, Zhu KQ, Liang Z, Anthony J, Engrav LH, Gibran NS. 2005. Substance P levels and neutral endopeptidase activity in acute burn wounds and hypertrophic scar. Plast Reconstr Surg. 115:1095-1102.
28. Singer AJ, Clark RA. 1999. Cutaneous wound healing. N Engl J Med. 341:738-746.
29. Spenny ML, Muangman P, Sullivan SR, Bunnett NW, Ansel JC, Olerud JE, Gibran NS. 2002. Neutral endopeptidase inhibition in diabetic wound repair. Wound Repair Regen. 10:295-301.
30. Star RA, Rajora N, Huang J, Stock RC, Catania A, Lipton JM. 1995. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A. 92:8016-8020.
31. Sturm RA. 2009. Molecular genetics of human pigmentation diversity. Hum Mol Genet. 18:R9-R17.
32. Sullivan SR, Underwood RA, Gibran NS, Sigle RO, Usui ML, Carter WG, Olerud JE. 2004. Validation of a model for the study of multiple wounds in the diabetic mouse (db/db). Plast Reconstr Surg. 113:953-960.
33. Suzuki I, Cone RD, Im S, Nordlund J, Abdel-Malek ZA. 1996. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology. 137:1627-1633.
34. Tsatmali M, Graham A, Szatkowski D, Ancans J, Manning P, McNeil CJ, Graham AM, Thody AJ. 2000. Alpha-melanocytestimulating hormone modulates nitric oxide production in melanocytes. J Invest Dermatol. 114:520-526.